• 1.0
• NY N331005
• Mar 07, 2023

• Type: Classification • HTSUS: 3002.15.0091; 3004.90.9209
  

The tariff classification of clinical trial kits from the United States

• 1.0
• NY N290237
• Oct 12, 2017

• Type: Classification • HTSUS: 3002.15.0000
  

The tariff classification of Anti-beta Catenin antibody [E247] (ab32572). No country of origin was provided.

• 1.0
• NY N314693
• Oct 22, 2020

• Type: Classification • HTSUS: 3002.15.0090
  

The tariff classification of various recombinant proteins packed for retail sale from India

• 1.0
• NY N301102
• Nov 07, 2018

• Type: Classification • HTSUS: 3002.15.0000
  

The tariff classification of Brazikumab (MEDI2070) and Brazikumab (AMG 139 MEDI2070) (CAS No. 1610353-18-8) in dosage form, from the United States and imported from Ireland

• 1.0
• NY N294763
• Aug 10, 2018

• Type: Classification • HTSUS: 3002.15.0000
  

The tariff classification of Gammagard Liquid® and Gammagard SD® from an unspecified country

• 1.0
• NY N294981
• Nov 01, 2018

• Type: Classification • HTSUS: 3002.15.0000
  

The tariff classification of Anti-trimethyl-Histone H3 (Lys9) polyclonal antibody packed for retail sale from Canada

• 1.0
• NY N300608
• Oct 11, 2018

• Type: Classification • HTSUS: 3002.15.0000
  

The tariff classification of Fulphila™ (Pegfilgrastim-jmdb) Injection in dosage form, from India

• 1.0
• NY N298294
• Jul 17, 2018

• Type: Classification • HTSUS: 3002.15.0000
  

The tariff classification of the SNAP Beta ST Plus Test Kit (Product Number 99-0004704), from the United States and other countries

• 1.0
• NY N312795
• Jul 22, 2020

• Type: Classification • HTSUS: 3002.15.0000
  

The tariff classification of polyclonal rabbit antibodies from India

• 1.0
• NY N307458
• Nov 26, 2019

• Type: Classification • HTSUS: 3002.15.0000
  

The tariff classification of Ogivri ™ (Trastuzumab-dkst for Injection) in dosage form, from India